33 modeling-and-simulation-post-doc Postdoctoral positions at University of Cambridge
Sort by
Refine Your Search
-
should be directed to tbi-reporter@medschl.cam.ac.uk in the first instance. Fixed-term: The funds for this post are available until 30th September 2028 in the first instance. Once an offer of employment
-
to develop and improve current simulation methods (quantum and classical) to study such systems. The overarching aim of the post-doctoral position is to develop and apply computational approaches that enable
-
Fixed-term: The funds for this post are available until 30 September 2027. Applications are invited for a full-time Research Assistant/Associate to work on the design and implementation of next
-
Fixed-term: The funds for this post are available for 1 year in the first instance. The faculty of Economics is looking to hire a Postdoctoral Research Associate starting August 2025, although
-
modelling to study the causes and consequences of extreme chromosomal instability in these cancers. The role will involve: - Learning and applying cytogenetic methods for generation and analysis of chromosome
-
the cellular and molecular mechanisms driving tumour development. In this role, you will support a team of scientists using genetically engineered mouse models (GEMMs) and transplantable tumour models (e.g
-
research centre well-known for its close-knit community, friendly atmosphere, and outstanding research support. We are seeking a post-doctoral research associate with experience in computational approaches
-
, BRCA2, and PALB2. Through advanced single cell genomics, in vivo modelling, and immune profiling, the team will study early molecular and cellular changes that occur in high-risk breast tissue. The team
-
Investigator based in Zoology and will be mentored by an experienced post-doc. There will be opportunities to contribute to training new team members as the group expands and to general project management, as
-
data models for electronic health records of people with mental disorders, under the guidance of Dr Osimo and Prof Murray at Cambridge, and a line manager to be selected at Akrivia Health. The aim